Cheap Calories, Expensive Consequences: How Federal Policy Contributes to Chronic Disease

Lilly's Next-Gen Weight-Loss Drug Clears Trial With Near-Bariatric Surgery Results Eli Lilly reported positive Phase 3 results for its next-generation obesity drug, retatrutide, which delivered weight-loss results on par with those of bariatric surgery. In the TRIUMPH-1 trial, overweight adults, but without diabetes, achieved meaningful weight loss across all tested doses after 80 weeks: 12 mg dose: average weight loss of 70.3 pounds, or 28.3% of body weight. 9 mg dose: average weight loss of 64.4 pounds, or 25.9%. 4 mg dose: average weight loss of 47.2 pounds, or 19% Ahead of the results,...

Japanic: Yen Suddenly Spikes Stoking Intervention Speculation Having collapsed to its weakest relative to the dollar in 40 years, it appears the Ministry of Finance and Bank of Japan has had enough and intervened. Having tagged 164/USD, the Japanese currency suddenly exploded stronger (below 160/USD, which was the prior level of intervention)... The scale of the move is commensurate with the last large intervention in April. Obviously, there is no confirmation, yet, but the timing, coming after the Fed and after Japan markets have closed, would certainly fit what we know about the...

Ukraine's 'Mood Swing' Against Zelensky: Widespread Fraud, Wartime Protests, Unpopular Dismissals The mainstream media is turning on Ukrainian President Volodymyr Zelensky, and more and more of his population may be doing the same, at a moment of multiple high level corruption cases running straight through the presidential office. To review, this was the second straight summer that controversial decisions by Zelensky sparked rare war time protests in Ukraine. In summer of 2025, Zelensky moved to weaken and de-legitimize two key national anti-corruption bodies. After, he came under immense pressure, also from Europe, and...